Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
2,017
+8
+0.4% +$936 0.1% 142
2026
Q1
$242K Buy
2,009
+22
+1% +$2.54K 0.11% 144
2025
Q4
$210K Buy
+1,987
New +$187K 0.09% 153

Other funds holding MRK

Optima Capital's MRK Position: Q2 2026 in Review

Optima Capital increased its Merck (MRK) stake by 0.4% in Q2 2026, buying an estimated $936 and bringing the position to 2,017 shares worth $260K. The position accounts for 0.1% of the portfolio, ranked #142.

Optima Capital first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,332 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Optima Capital held 2,017 shares of Merck worth $260K as of Q2 2026.
  • Optima Capital bought 8 Merck shares in Q2 2026, an estimated $936.
  • Merck made up 0.1% of Optima Capital's portfolio in Q2 2026, its #142 holding.
  • Optima Capital first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Optima Capital's 13F filing for Q2 2026, filed 24 Jul 2026.